J. Atack

发表

An inverse agonist selective for α5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze

D. Stephens, J. Atack, N. Collinson, 2006, Psychopharmacology.

Role of the histidine residue at position 105 in the human α5 containing GABAA receptor on the affinity and efficacy of benzodiazepine site ligands

M. D. Kelly, J. Atack, K. Maubach, 2002, British journal of pharmacology.

GABAA α1 subunit knock-out mice do not show a hyperlocomotor response following amphetamine or cocaine treatment

G. Dawson, P. Whiting, T. Rosahl, 2003, Neuropharmacology.

Density and pharmacology of α5 subunit-containing GABAA receptors are preserved in hippocampus of Alzheimer’s disease patients

R. Mckernan, J. Atack, D. Dewar, 2000, Neuroscience.

Both α2 and α3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm

D. Stephens, J. Atack, D. Reynolds, 2006, The European journal of neuroscience.

Cell surface expression of the human N-methyl-d-aspartate receptor subunit 1a requires the co-expression of the NR2A subunit in transfected cells

P. Whiting, R. Mcilhinney, J. Atack, 1996, Neuroscience.

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

R. Mckernan, P. Whiting, J. Atack, 2000, Nature Neuroscience.

Alpha2-containing GABAA receptors are involved in mediating stimulant effects of cocaine

G. Dawson, D. Stephens, T. Rosahl, 2008, Pharmacology Biochemistry and Behavior.

CSF galanin and neuropeptide Y immunoreactivity in progressive supranuclear palsy

I. Litvan, T. Chase, J. Atack, 1992, Acta neurologica Scandinavica.

An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

N Collinson, B. Everitt, J. Atack, 2006, Journal of Pharmacology and Experimental Therapeutics.

MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans

G. Bormans, K. Van Laere, S. Tye, 2011, Journal of psychopharmacology.

Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist

Sandra M. Sanabria-Bohórquez, G. Bormans, K. Van Laere, 2011, Journal of psychopharmacology.

Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for alpha 1 versus alpha 2 and alpha 3 subunit-containing GABAA receptors.

R. Mckernan, F. Emms, A. Smith, 1999, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Rodent pharmacokinetics and receptor occupancy of the GABAA receptor subtype selective benzodiazepine site ligand L‐838417

P. Worboys, J. Atack, P. Scott-Stevens, 2005, Biopharmaceutics & drug disposition.

Characterization of [35S]t‐butylbicyclophosphorothionate ([35S]TBPS) binding to GABAA receptors in postmortem human brain

R. Mckernan, J. Atack, J. Atack, 2007, British journal of pharmacology.

Differential expression of cytochrome oxidase (COX) genes in different regions of monkey brain

S. Rapoport, T. Giordano, K. Chandrasekaran, 1992, Journal of neuroscience research.

Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux.

C. Adkins, R. Mckernan, K. Wafford, 2001, Molecular pharmacology.

Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy

J. Grafman, P. Nichelli, I. Litvan, 1994, Annals of neurology.